Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Stephen Hughes

Stephen Hughes is senior specialist pharmacist, anti-infectives, Chelsea and Westminster NHS Foundation Trust, London.

Recent stories

  • IV at home

    Why the newly licensed antibiotic cefepime should be introduced to UK formulariesSubscription

    9 OCT 2019

    Healthcare trusts should consider introducing the antibiotic cefepime to their outpatient parenteral antimicrobial therapy services to tackle infections that are becoming resistant to carbapenem antibiotics.

  • A petri dish showing a zone of inhibition surrounded by fungi

    How to improve antifungal stewardshipSubscription

    19 JUL 2019

    Selecting appropriate antifungal therapies and performing ongoing reviews of these therapies can help support antifungal stewardship efforts and help reduce antifungal resistance.

  • Scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria

    Antimicrobial therapies for Gram-positive infectionsSubscription

    12 SEP 2017

    Gram-positive bacteria are among the most common human pathogens associated with clinical infections, which range from mild skin infections to sepsis. In an era defined by antimicrobial resistance (AMR) and an increasing drive toward delivering patient care via ambulatory pathways, the paradigm for the management of infections is changing. Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), the best known cases of Gram-posi

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.